'Medicare For All' Bills Prompt Warning From Former US FDA Commissioner Gottlieb

In an address to the National Press Club on 10 May, former FDA Commissioner Scott Gottlieb pointed to some of the challenges that CMS would face in supplying coverage for new technology, should a "Medicare for All" bill be adopted by Congress and signed by the president. Medtech Insight analyzed provisions that could impact industry in some of the proposed bills, in a comparative chart.

FDA Commissioner Scott Gottlieb discussed reimbursement challenges for medical products at the National Press Club in Washington, DC, with its President Alison Fitzgerald Kodjak.
Former FDA Commissioner Scott Gottlieb discussed challenges with "Medicare For All" bills at the National Press Club with club president Alison Fitzgerald Kodjak • Source: Michael Cipriano

More from Legislation

More from Policy & Regulation